SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 4.07 |
| Enterprise Value ($M) | 0.91 |
| Book Value ($M) | 1.56 |
| Book Value / Share | 0.29 |
| Price / Book | 2.61 |
| NCAV ($M) | 1.56 |
| NCAV / Share | 0.29 |
| Price / NCAV | 2.61 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -7.87 |
| Return on Assets (ROA) | -2.37 |
| Return on Equity (ROE) | -3.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.79 |
| Current Ratio | 1.79 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 3.53 |
| Assets | 3.53 |
| Liabilities | 1.97 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -12.51 |
| Net Income | -12.29 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -11.16 |
| Cash from Investing | 0.00 |
| Cash from Financing | 6.89 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Proehl Gerald T | 13.30 | 245.06 | |
| 13G/A | Armistice Capital, Llc | 9.99 | 48.45 | |
| 13G | Intracoastal Capital, Llc | 6.70 | 82.34 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 92,398 | 239,696 | 38.55 | |
| 40,939 | 166,529 | 24.58 | |
| 173,061 | 432,402 | 40.02 | |
| 69,548 | 109,502 | 63.51 | |
| 13,823 | 40,518 | 34.12 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DERM – Journey Medical Corporation | DMAC – DiaMedica Therapeutics Inc. |
| DNTH – Dianthus Therapeutics, Inc. | DRRX – DURECT Corporation |
| DRUG – Bright Minds Biosciences Inc. |
Financial data and stock pages provided by
Fintel.io